OneMedNet Enters Its 12th Channel Partner Agreement With A Global Pharmaceutical Intelligence And Data Solutions Provider To Distribute Its Clinical Data; Terms Not Disclosed

OneMedNet has entered its 12th channel partner agreement with a global pharmaceutical intelligence and data solutions provider to distribute its clinical data, although the terms of the agreement were not disclosed. This partnership aims to enhance OneMedNet's presence in the rapidly growing Real-World Data market, projected to increase from approximately $2.7 billion in 2026 to $7.1 billion by 2033. The company emphasizes the value of its first-party data sourced directly from healthcare providers, which is de-identified and delivered at regulatory-grade quality, supporting pharmaceutical customers in various areas including clinical development and regulatory submissions.